The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
06/30/2022 | Angus Stewart
The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.
06/29/2022 | Angus Stewart | 4 min read
What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.
06/29/2022 | Ben Perry | 4 min read
This is the story of how DNDi put forward a new model for collaborative, open science.
06/28/2022 | Angus Stewart | 6 min read
Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.
06/27/2022 | Angus Stewart | 6 min read
How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2
06/17/2022 | Maryam Mahdi
How pharma is working to develop efficient and patient-centric trials.
06/10/2022 | Stephanie Sutton | 2 min read
A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.
05/31/2022 | Angus Stewart | 5 min read
An inside view on the San Diego company working to bring drug delivering contact lenses to market.
05/12/2022 | Angus Stewart
This Scottish company is developing a thin film that could improve medicine adherence in the elderly
05/06/2022 | Angus Stewart
The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse